Masaharu Nohgawa
Overview
Explore the profile of Masaharu Nohgawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
184
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maeda T, Matsuda A, Kanda J, Kawabata H, Ishikawa T, Tohyama K, et al.
Br J Haematol
. 2024 Jan;
204(5):2086-2096.
PMID: 38296352
Morphological dysplasia in haematopoietic cells, defined by a 10% threshold in each lineage, is one of the diagnostic criteria for myelodysplastic neoplasms. Dysplasia limited to the erythroid lineage has also...
2.
Effects of combined test dose and therapeutic drug monitoring strategy in exposure-directed busulfan
Iemura T, Kondo T, Ueda A, Maeda T, Kitawaki T, Arai Y, et al.
Ann Hematol
. 2023 Apr;
102(10):2909-2922.
PMID: 37052663
Although exposure-directed busulfan (BU) dosing can improve allogeneic hematopoietic stem cell transplantation outcomes, there is still large variability in BU exposure with test dose alone due to changes in BU...
3.
Morita-Fujita M, Shindo T, Iemura T, Arai Y, Kanda J, Okada K, et al.
Transplant Cell Ther
. 2023 Mar;
29(6):347.e1-347.e11.
PMID: 36889508
Cord blood transplantation (CBT) is an attractive therapeutic option for patients with hematologic malignancies. CBT tolerates HLA mismatches between donors and recipients, but the HLA mismatches that generate graft-versus-tumor (GVT)...
4.
Oka S, Ono K, Nohgawa M
Ann Hematol
. 2022 Aug;
101(10):2353-2354.
PMID: 35943589
No abstract available.
5.
Iemura T, Arai Y, Kitawaki T, Kanda J, Kondo T, Ueda Y, et al.
Bone Marrow Transplant
. 2022 Mar;
57(5):781-789.
PMID: 35236933
Viral infection is one of the lethal adverse events after cord blood transplantation (CBT). Human leukocyte antigen (HLA) and killer immunoglobulin-like receptor (KIR) ligand divergences can increase the risk of...
6.
Tanaka Y, Mishina T, Miyoshi H, Ohshima K, Nohgawa M
J Med Cases
. 2022 Feb;
13(1):15-20.
PMID: 35211230
Patients with intestinal T-cell lymphomas (ITLs) usually present with perforation of the small intestine and colon at diagnosis. At relapse or in the advanced stage, ITLs involve in other extranodal...
7.
Muranushi H, Kanda J, Kobayashi M, Maeda T, Kitano T, Tsuji M, et al.
Hematology
. 2022 Feb;
27(1):239-248.
PMID: 35152852
Objectives: We conducted a phase II trial to prospectively evaluate the efficacy and safety of bortezomib-cyclophosphamide-dexamethasone (VCD) induction, autologous stem cell transplantation (ASCT), VCD consolidation, and bortezomib maintenance in transplant-eligible...
8.
Wada F, Kanda J, Yoshioka S, Ishikawa T, Akasaka T, Ueda Y, et al.
Transplantation
. 2021 Dec;
106(6):1279-1287.
PMID: 34935764
Background: Unrelated cord blood (UCB) and haploidentical related donor transplantation using posttransplant cyclophosphamide (PTCy-haplo) have become alternative options to treat patients with hematological malignancies without a HLA-matched donor. Methods: We...
9.
Iwasaki M, Kanda J, Arai Y, Kondo T, Ishikawa T, Ueda Y, et al.
Blood Adv
. 2021 Dec;
6(8):2618-2627.
PMID: 34933327
Graft-versus-host disease-free, relapse-free survival (GRFS) is a useful composite end point that measures survival without relapse or significant morbidity after allogeneic hematopoietic stem cell transplantation (allo-HSCT). We aimed to develop...
10.
Hori H, Tanaka Y, Nakayama R, Nohgawa M
Intern Med
. 2021 Sep;
61(5):729-733.
PMID: 34471023
A 77-year-old woman presented with systemic lymphadenopathy and bilateral pleural effusion. Angioimmunoblastic T-cell lymphoma (AITL) was diagnosed based on the results of a lymph node biopsy. AITL cells expressed the...